#Canada #Toronto #Normal Course Issuer Bid #Auxly Cannabis Group #TSX XLY

Auxly Cannabis Group's New Normal Course Issuer Bid

Auxly Cannabis Group Inc., a prominent name in the Canadian cannabis product market, has officially announced its plan to implement a Normal Course Issuer Bid (NCIB). This strategic move, aimed at enhancing shareholder value, comes into effect following the acceptance of the company's notice by the Toronto Stock Exchange (TSX).

The NCIB allows Auxly to repurchase up to 68.9 million common shares, which constitutes less than 5% of the company’s outstanding shares as of early April 2026. This repurchase strategy is scheduled to commence on April 20, 2026, and will conclude no later than April 19, 2027, barring early completion of the repurchases.

Purpose Behind the Buyback

The company asserts that there are times when the market does not accurately reflect the true value of its common shares. By repurchasing its own stock during such periods, Auxly believes it can optimize its resources and ultimately bolster shareholder confidence and value. The decision to execute this buyback is informed by the trading activities observed over the past six months, and the NCIB is expected to be executed at prevailing market prices, ensuring transparency and compliance with relevant market regulations.

Auxly has set a daily purchase limit of 206,920 shares of its common stock as per TSX’s average trading volumes. Any shares repurchased will immediately be canceled, reflecting a direct approach to managing the company’s share structure and value perception.

Funding and Management of the Buyback

The funding for the NCIB will come from Auxly's available cash reserves, and to facilitate purchases during times when trading restrictions apply (like blackout periods), the company has enacted an Automatic Share Purchase Plan (ASPP) with a designated broker.

This proactive strategy not only underscores Auxly's commitment to maximizing shareholder returns but also demonstrates the management’s confidence in the business's future prospects and financial health. With 1,405,038,794 shares issued and a public float of 1,053,217,980 shares, this buyback represents a significant step in enhancing liquidity and market presence.

About Auxly Cannabis Group

Headquartered in Toronto, Auxly is a leading player in the Canadian cannabis industry, known for its commitment to quality, safety, and customer satisfaction. The company aims to provide consumers with cannabis products that enhance their well-being.

Auxly's strategic choices, like the NCIB, are designed to align with its broader vision of establishing a solid and trustworthy brand in the ever-evolving cannabis landscape. The decision to initiate share buybacks is viewed positively by industry analysts, as it reflects an overarching confidence in both the operational and financial strategies in place.

With this initiative, Auxly not only seeks to stabilize its stock price but also reaffirms its commitment to shareholder value, promising sustained growth in the competitive cannabis market.

For ongoing updates, stakeholders are encouraged to follow Auxly on their social media platforms or visit the official website.